Isothiocyanates as novel cytotoxic and cytostatic agents:: molecular pathway on human transformed and non-transformed cells

被引:45
作者
Fimognari, C [1 ]
Nüsse, M
Berti, F
Iori, R
Cantelli-Forti, G
Hrelia, P
机构
[1] Univ Bologna, Dept Pharmacol, I-40126 Bologna, Italy
[2] GSF Flow Cytometry Grp, D-85758 Neuherberg, Germany
[3] MiPAF, Ist Sperimentale Colture Ind, Bologna, Italy
关键词
isothiocyanates; apoptosis; cell cycle; cancer cells; non-transformed cells; selectivity;
D O I
10.1016/j.bcp.2004.03.044
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cancer chemoprevention is a new approach in the management of cancer. Traditional cytotoxic chemotherapeutic approaches cannot cure most advanced solid malignancies. Chemoprevention can be defined as the use of non-cytotoxic drugs and natural agents to block the progression to invasive cancer. Recently, isothiocyanates, natural products found in the diet of humans, has been shown to function as cancer chemopreventive agents. They are strong inhibitors of phase I enzymes and inducers of phase 11 enzymes. They can also induce apoptosis and modulate cell-cycle progression of highly proliferating cancer cells. This commentary will review the mechanism of apoptosis and growth inhibition mediated by different isothiocyanates. Particular attention will be given to the effects of the new isothiocyanate 4-(methylthio)butylisothiocyanate (MTBITC). Since selective targeting and low toxicity for normal host tissues are fundamental requisites for proposed chemopreventive agents, we will also review the effects of different isothiocyanates on non-transformed human cells. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1133 / 1138
页数:6
相关论文
共 30 条
  • [1] RANKING POSSIBLE CARCINOGENIC HAZARDS
    AMES, BN
    MAGAW, R
    GOLD, LS
    [J]. SCIENCE, 1987, 236 (4799) : 271 - 280
  • [2] BENSON AM, 1978, CANCER RES, V38, P4486
  • [3] Chung FL, 1996, CANCER RES, V56, P772
  • [4] Inhibition of rat liver cytochrome P450 isozymes by isothiocyanates and their conjugates: A structure-activity relationship study
    Conaway, CC
    Jiao, D
    Chung, FL
    [J]. CARCINOGENESIS, 1996, 17 (11) : 2423 - 2427
  • [5] Duncan A. J., 1989, Aspects of Applied Biology, V19, P75
  • [6] Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane
    Fimognari, C
    Nüsse, M
    Cesari, R
    Iori, R
    Cantelli-Forti, G
    Hrelia, P
    [J]. CARCINOGENESIS, 2002, 23 (04) : 581 - 586
  • [7] The new isothiocyanate 4-(methylthio)butylisothiocyanate selectively affects cell-cycle progression and apoptosis induction of human leukemia cells
    Fimognari, C
    Nüsse, M
    Iori, R
    Cantelli-Forti, G
    Hrelia, P
    [J]. INVESTIGATIONAL NEW DRUGS, 2004, 22 (02) : 119 - 129
  • [8] Cyclin D3 and p53 mediate sulforaphane-induced cell cycle delay and apoptosis in non-transformed human T lymphocytes
    Fimognari, C
    Nüsse, M
    Berti, F
    Iori, R
    Cantelli-Forti, G
    Hrelia, P
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (11) : 2004 - 2012
  • [9] Selective cytostatic and cytotoxic effects of glucosinolates hydrolysis products on human colon cancer cells in vitro
    Gamet-Payrastre, L
    Lumeau, S
    Gasc, N
    Cassar, G
    Rollin, P
    Tulliez, J
    [J]. ANTI-CANCER DRUGS, 1998, 9 (02) : 141 - 148
  • [10] EFFECTS OF PHENETHYL ISOTHIOCYANATE, A CARCINOGENESIS INHIBITOR, ON XENOBIOTIC-METABOLIZING ENZYMES AND NITROSAMINE METABOLISM IN RATS
    GUO, ZY
    SMITH, TJ
    WANG, E
    SADRIEH, N
    MA, Q
    THOMAS, PE
    YANG, CS
    [J]. CARCINOGENESIS, 1992, 13 (12) : 2205 - 2210